Electron Transport Chain (see tricarboxylic acid section for Complex II), cytochrome c oxidase subunit 10
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A0A3S7WXI5
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 35 | 39 | PF00656 | 0.398 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.350 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.322 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.487 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.380 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.319 |
CLV_PCSK_PC7_1 | 47 | 53 | PF00082 | 0.322 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.295 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.571 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.313 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.567 |
DOC_CYCLIN_RxL_1 | 18 | 28 | PF00134 | 0.442 |
DOC_CYCLIN_yCln2_LP_2 | 23 | 29 | PF00134 | 0.433 |
DOC_PP1_RVXF_1 | 19 | 26 | PF00149 | 0.425 |
DOC_PP1_RVXF_1 | 60 | 67 | PF00149 | 0.317 |
DOC_PP1_RVXF_1 | 85 | 92 | PF00149 | 0.344 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.487 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.358 |
LIG_14-3-3_CanoR_1 | 100 | 105 | PF00244 | 0.342 |
LIG_14-3-3_CanoR_1 | 2 | 11 | PF00244 | 0.574 |
LIG_deltaCOP1_diTrp_1 | 88 | 98 | PF00928 | 0.446 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.291 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.586 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.578 |
LIG_FHA_2 | 80 | 86 | PF00498 | 0.348 |
LIG_HCF-1_HBM_1 | 111 | 114 | PF13415 | 0.315 |
LIG_LIR_Gen_1 | 63 | 73 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 63 | 69 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.287 |
LIG_REV1ctd_RIR_1 | 96 | 104 | PF16727 | 0.311 |
LIG_SH2_PTP2 | 101 | 104 | PF00017 | 0.291 |
LIG_SH2_SRC | 36 | 39 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.332 |
LIG_SH3_3 | 23 | 29 | PF00018 | 0.475 |
LIG_SUMO_SIM_par_1 | 30 | 35 | PF11976 | 0.384 |
LIG_TRAF2_1 | 82 | 85 | PF00917 | 0.429 |
MOD_CDK_SPxxK_3 | 79 | 86 | PF00069 | 0.352 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.341 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.293 |
MOD_N-GLC_1 | 79 | 84 | PF02516 | 0.340 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.330 |
MOD_PKA_1 | 2 | 8 | PF00069 | 0.571 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.571 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.488 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.359 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.393 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.458 |
TRG_ER_diArg_1 | 51 | 53 | PF00400 | 0.353 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKB5 | Leptomonas seymouri | 86% | 99% |
A0A0S4JCT0 | Bodo saltans | 71% | 100% |
A0A1X0NX91 | Trypanosomatidae | 74% | 100% |
A4HCQ2 | Leishmania braziliensis | 86% | 100% |
A4I077 | Leishmania infantum | 100% | 100% |
D0A9J4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 73% | 100% |
D0A9J6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 74% | 100% |
E9AW41 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QBD7 | Leishmania major | 98% | 100% |